Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q41489810)
Watch
English
Chemotherapy of advanced non-Hodgkin's lymphoma
scientific article published on October 1, 1979
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
retrieved
1 October 2017
title
Chemotherapy of advanced non-Hodgkin's lymphoma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A583032
retrieved
13 July 2022
main subject
oncology
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
author name string
A. T. Skarin
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A583032
retrieved
13 July 2022
G. P. Canellos
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A583032
retrieved
13 July 2022
language of work or name
English
1 reference
stated in
National Center for Biotechnology Information
PubMed publication ID
583032
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=583032
retrieved
13 July 2022
publication date
1 October 1979
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
retrieved
1 October 2017
full work available at URL
https://api.elsevier.com/content/article/PII:S0308226179800107?httpAccept=text/xml
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
https://api.elsevier.com/content/article/PII:S0308226179800107?httpAccept=text/plain
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
published in
Clinics in haematology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
retrieved
1 October 2017
volume
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
retrieved
1 October 2017
issue
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
retrieved
1 October 2017
page(s)
667-684
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
retrieved
1 October 2017
cites work
Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup
series ordinal
1
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Non-hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types.Results of sequential staging procedures, response to therapy, and survival of 100 patients
series ordinal
2
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Approaches to the treatment of acute leukemia and lymphoma in adults
series ordinal
3
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remission
series ordinal
4
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas
series ordinal
5
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Chemotherapy of the non-Hodgkin's lymphomas
series ordinal
8
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group
series ordinal
9
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Advanced diffuse histiocytic lymphoma, a potentially curable disease
series ordinal
11
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
1.3-Bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP): A new therapeutic regimen for diffuse histiocytic lymphoma
series ordinal
12
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma
series ordinal
13
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)
series ordinal
14
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Malignant lymphoma, small lymphocytic type: a clinicopathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma
series ordinal
15
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report
series ordinal
16
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma
series ordinal
17
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy
series ordinal
18
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combined modality therapy for advanced, diffuse lymphocytic and histiocytic lymphomas
series ordinal
20
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Diffuse well-differentiated lymphocytic lymphoma (DLWD).Response and survival
series ordinal
21
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases.
series ordinal
23
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combination versus successive single agent chemotherapy in lymphocytic lymphoma
series ordinal
24
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combination therapy of the lymphomas
series ordinal
25
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Treatment of histiocytic and mixed lymphomas.A comparison of two, three and four drug chemotherapy
series ordinal
26
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type
series ordinal
27
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology
series ordinal
28
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Immunologic characterization of human malignant lymphomas
series ordinal
29
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Curability of non-Hodgkin's lymphomas
series ordinal
32
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma
series ordinal
33
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Malignant lymphoma, lymphoblastic
series ordinal
34
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Non-hodgkin's lymphomas.A clinicopathologic study comparing two classifications
series ordinal
35
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B
series ordinal
36
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Chemotherapy of the non-Hodgkin's lymphomas: the Stanford experience
series ordinal
37
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
No Initial Therapy for Stage III and IV Non-Hodgkin's Lymphomas of Favorable Histologic Types
series ordinal
38
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Convoluted lymphocytic lymphoma in adults: a clinicopathologic entity
series ordinal
42
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Non-Hodgkin's lymphoma: Patterns of relapse from complete remission after combination chemotherapy
series ordinal
43
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma
series ordinal
44
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combination chemotherapy of advanced lymphocytic lymphoma:Importance of histologic classification in evaluating response
series ordinal
46
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
New agents and combination chemotherapy of non-Hodgkin's lymphoma
series ordinal
47
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP)
series ordinal
48
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
High-dose methotrexate with folinic acid in the treatment of advanced non-Hodgkin lymphoma including CNS involvement
series ordinal
49
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Combination chemotherapy of lymphomas other than Hodgkin's disease
series ordinal
51
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination
series ordinal
55
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience
series ordinal
56
1 reference
stated in
Crossref
DOI
10.1016/S0308-2261(79)80010-7
reference URL
https://api.crossref.org/works/10.1016/S0308-2261(79)80010-7
retrieved
23 July 2023
Identifiers
DOI
10.1016/S0308-2261(79)80010-7
1 reference
stated in
National Center for Biotechnology Information
PubMed publication ID
583032
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=583032
retrieved
13 July 2022
PubMed publication ID
583032
1 reference
stated in
Europe PubMed Central
PubMed publication ID
583032
retrieved
1 October 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit